OCRA’s Schreiber Research Grants Program, named after Ann and Sol Schreiber, founders of Ovarian Cancer Research Alliance, supports postdoctoral fellows, early career independent investigators, and teams of experienced investigators.
Wherever you are in your research career, OCRA has a grant program to suit you.
This article was updated in May 2025 to reflect NCCN’s release of the 2025 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of 2025 Cervical Cancer Updates. We … Continued
The Food and Drug Administration has granted accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), made by Verastem Oncology, making it the first FDA-approved treatment for patients with … Continued
Ovarian Cancer Research Alliance is proud to support five outstanding scientists through our Early Career Investigator Grants, part of the $6 million in new research OCRA is funding in 2025. These … Continued
Get email updates about research news, action alerts, and ways to join the fight.
